ARTICLES BY THIS AUTHOR
- 10/4/2019
NACDS 21st annual Foundation Dinner to feature entertainer Jim Gaffigan
Grammy award-nominated entertainer Jim Gaffigan will headline NACDS Foundation dinner, which is dedicated to improving patient outcomes and public health. - 10/4/2019
Schnucks set to end tobacco sales in January
Beginning Jan. 1, 2020 Schnuck Markets will end all tobacco product sales, and starting Oct. 15 it will offer double Schnucks Rewards points on all OTC smoking cessation products. - 10/4/2019
FDA approves Gilead’s Descovy as PrEP
Descovy is the second FDA approved to prevent HIV infection. - 10/4/2019
FDA approves new indication for AbbVie’s Mavyret
Mavyret is now the first eight-week treatment approved for all treatment-naïve adult and certain pediatric patients with HCV genotypes 1-6 both without cirrhosis and with compensated cirrhosis. - 10/4/2019
Superstars: Pharmacists who went beyond the call of duty
DSN found some of the many pharmacists who do more than asked. Here are their stories. - 10/4/2019
Alembic launches generic Optivar
Alembic's azelastine ophthalmic solution 0.05% is provided as 6mL in a sterile dispensing bottle. - 10/4/2019
Albertsons to switch to recycled prescription bags
Albertsons’ move to recycled prescription bags will save more than 5,000 trees each year, the company said. - 10/3/2019
Teva promotes Eric Drapé to executive vice president of global operations
After more than seven years leading Teva global operations, Carlo de Notaristefani, will retire from Teva. - 10/3/2019
MedicaSafe partners with Amneal on generic Suboxone monitoring
MedicaSafe will combine Amneal's generic of Suboxone (buprenorphine and naloxone) with its smart medication systems to treat opioid dependence. - 10/3/2019
Diplomat taps David Skomo as CastiaRx COO
Following the retirement of Chris Luthin, David Skomo has been named COO of Diplomat's pharmacy benefit manager CastiaRx.